Feasibility and Preliminary Efficacy of an Exercise Telephone Counseling Intervention for Hematologic Cancer Survivors: a Phase II Randomized Controlled Trial
Overview
Affiliations
Background: Supervised exercise interventions produce the largest improvements in patient-reported outcomes in cancer survivors but their scalability has been questioned. Telephone counseling has been proposed as a more feasible alternative but its impact on exercise behavior and health outcomes have been modest. Basing telephone counseling exercise (TCE) interventions on the theoretical advances described in the multi-process action control framework (M-PAC) may improve these outcomes.
Purpose: To assess the feasibility and preliminary efficacy of a M-PAC-based TCE intervention for increasing aerobic exercise behavior in hematologic cancer survivors (HCS).
Methods: We recruited 51 HCS who were randomized to either a weekly TCE group (n = 26) or a self-directed exercise (SDE) group (n = 25). Participants completed online measures of self-reported aerobic exercise behavior, quality of life (QoL), fatigue, and program satisfaction at baseline and post-intervention (12 weeks).
Results: Adherence to the TCE intervention was 93% and retention was 100%. Participants receiving TCE increased their weekly aerobic exercise by 218 min compared to 93 min in the SDE group [mean-adjusted between-group difference (MBGD) = 139, 95%CI = 65 to 213, p < .001, effect size (d) = 2.19]. Clinically meaningful QoL improvements favored the TCE group for mental health (MBGD = 3.7, 95%CI = - 0.4 to 7.9, p = .08, d = 0.42) and mental health component (MBGD = 3.6, 95%CI = - 0.8 to 8.1, p = .10, d = 0.35) subscales.
Conclusions: The 12-week TCE intervention substantially increased exercise behavior and may have meaningfully improved QoL in HCS.
Implications For Cancer Survivors: Though more definitive trials are needed, remote TCE interventions based on the M-PAC may improve exercise behavior and QoL in HCS and perhaps other cancer survivor groups.
Trial Registration Number: Clinical Trials ID: NCT03052777.
Costa J, Lucas A, Mihalko S, Brubaker P, Marshall A, Leitzelar B Pilot Feasibility Stud. 2025; 11(1):6.
PMID: 39810280 PMC: 11731389. DOI: 10.1186/s40814-024-01580-7.
Jarden M, Lindholm S, Kaldan G, Gronset C, Larsen R, Larsen A Cancers (Basel). 2024; 16(17).
PMID: 39272820 PMC: 11393877. DOI: 10.3390/cancers16172962.
Telemedicine Applications for Cancer Rehabilitation: Scoping Review.
Goncalves Leite Rocco P, Mahony Reategui-Rivera C, Finkelstein J JMIR Cancer. 2024; 10:e56969.
PMID: 39079103 PMC: 11375396. DOI: 10.2196/56969.
Cheung D, Kwok T, Liu S, Rhodes R, Chiang C, Lin C Internet Interv. 2024; 36:100730.
PMID: 38481576 PMC: 10933462. DOI: 10.1016/j.invent.2024.100730.
Physical activity and pain in people with cancer: a systematic review and meta-analysis.
Peters M, Butson G, Mizrahi D, Denehy L, Lynch B, Swain C Support Care Cancer. 2024; 32(3):145.
PMID: 38321248 PMC: 10847204. DOI: 10.1007/s00520-024-08343-3.